Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadera Sweiss

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Cellular & Molecular Immunology|June 15, 2019
Macrophages are the primary effector cells in IL-7-induced arthritisSeung-Jae Kim, Huan J Chang, Michael V Volin, et al.
Cellular & Molecular Immunology|March 4, 2026
Tofacitinib repairs inflammation and mitochondrial dysregulation in GM-CSF-reprogrammed RA macrophagesNeha Satoeya, Stephanie R Zack, Osama Al Zoubi, et al.
European Journal of Respiratory Medicine|February 23, 2024
Examination of eQTL Polymorphisms Associated with Increased Risk of Progressive Complicated Sarcoidosis in European and African Descent SubjectsNancy G Casanova, Sara M Camp, Manuel L Gonzalez-Garay, et al.
Arthritis and Rheumatism|February 28, 2009
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trialLorinda Chung, Lee Shapiro, David Fiorentino, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health OutcomesLesley Ann Saketkoo, Anne-Marie Russell, Kelly Jensen, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical toolMarc A Judson, Ulrich Costabel, Marjolein Drent, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Cellular & Molecular Immunology|June 15, 2019
Macrophages are the primary effector cells in IL-7-induced arthritisSeung-Jae Kim, Huan J Chang, Michael V Volin, et al.
Cellular & Molecular Immunology|March 4, 2026
Tofacitinib repairs inflammation and mitochondrial dysregulation in GM-CSF-reprogrammed RA macrophagesNeha Satoeya, Stephanie R Zack, Osama Al Zoubi, et al.
European Journal of Respiratory Medicine|February 23, 2024
Examination of eQTL Polymorphisms Associated with Increased Risk of Progressive Complicated Sarcoidosis in European and African Descent SubjectsNancy G Casanova, Sara M Camp, Manuel L Gonzalez-Garay, et al.
Arthritis and Rheumatism|February 28, 2009
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trialLorinda Chung, Lee Shapiro, David Fiorentino, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health OutcomesLesley Ann Saketkoo, Anne-Marie Russell, Kelly Jensen, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical toolMarc A Judson, Ulrich Costabel, Marjolein Drent, et al.
Pageof 5